United States Dengue Testing Market Size, Share, Trends - Exclusive Report by DatamIntelligence

"Dengue Testing Market is expected to grow at a high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/dengue-testing-market?sp

United States: Recent Industry Developments

✅ In October 2025, InBios International, a Seattle-based diagnostics company, offers the DENV DetectTM NS1 ELISA, an FDA-cleared test for early dengue detection through NS1 antigen identification within the first seven days of symptom onset.

✅ In September 2025, AccuQuikTM manufactures CE and ISO-certified dengue test kits, including the Dengue IgG/IgM Rapid Test, suitable for use in developing regions. These kits detect dengue virus NS1 antigen and immunoglobulin M antibodies.

✅ In August 2025, Abbott launched its BiolineTM Dengue Duo kit, which detects both dengue virus NS1 antigen and IgG/IgM antibodies in human serum, plasma, or whole blood, facilitating identification of patients at any stage of dengue infection.

✅ In July 2025, Quest Diagnostics offers a Dengue Fever Antibodies (IgG, IgM) and NS1 Antigen Panel, developed and validated in accordance with CLIA regulations, aiding in accurate diagnosis of dengue infections.

Japan: Recent Industry Developments

✅ In October 2025, InTec specializes in the Rapid Dengue Duo (NS1 Ag & IgM/IgG Ab) Test, a CE-marked kit with high sensitivity and specificity, designed for qualitative detection of both dengue virus NS1 antigen and IgM/IgG antibodies in human samples.

✅ In September 2025, Reszonics offers the RVR Dengue Combo NS1 & IgG/IgM Rapid Test, a lateral flow immunoassay for simultaneous detection and differentiation of IgG anti-dengue virus, IgM anti-dengue virus, and dengue antigen in human serum, plasma, or whole blood.

✅ In August 2025, Tauns Laboratories launched a rapid NS1 antigen test for early-stage dengue detection in clinical and field settings. The test is highly sensitive and suitable for large-scale outbreak screening.

✅ In July 2025, Fujirebio introduced a high-throughput dengue IgM/IgG antibody assay for hospital laboratories, enabling faster and accurate detection of dengue infections to support timely treatment and epidemiological monitoring.

Dengue Testing Market: Drivers

The dengue testing market is witnessing robust growth, driven by increasing prevalence of dengue infections, especially in tropical and subtropical regions, and rising demand for early and accurate disease diagnosis. Dengue diagnostic tests, including rapid diagnostic tests (RDTs), ELISA, PCR-based assays, and NS1 antigen tests, are essential for timely detection, disease monitoring, and guiding appropriate clinical management. Advances in point-of-care testing, molecular diagnostics, and multiplex assay platforms are enhancing sensitivity, specificity, and turnaround time, making testing more accessible and reliable. Expansion of healthcare infrastructure, government-led dengue surveillance programs, and awareness campaigns are further supporting market adoption. Growing emphasis on early detection, outbreak control, and preventive care is boosting demand for advanced dengue diagnostic solutions globally.

Leading companies, such as Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, and CTK Biotech, are developing innovative dengue testing solutions with improved accuracy, portability, and user-friendly designs suitable for both clinical and field settings. Research into rapid molecular assays, multiplex detection kits, and smartphone-integrated diagnostic platforms is expanding testing capabilities and accessibility. Strategic collaborations between diagnostic manufacturers, public health agencies, and research institutions are accelerating product development, regulatory approvals, and market deployment. Increasing awareness among healthcare providers, communities, and policymakers about dengue prevention and timely diagnosis is driving adoption. With continuous technological advancements, rising incidence of dengue, and expanding diagnostic infrastructure, the dengue testing market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dengue-testing-market?sp

Dengue Testing Market: Major Players

Abbott Laboratories, NovaTec Immundiagnostica GmbH, Euroimmun AG (PerkinElmer), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., InBios International, Inc, Quest Diagnostics, Certest Biotec S.L, OriGene Technologies and Abnova Corporation, Suzhou alesa biotechnology co., LTD, Ningbo Mingzhou Biotechnology Co., Ltd, Hunan Praterze Biotechnology Co., Ltd.

Segment Covered in the Dengue Testing Market:

➥ By Test Type: ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Other Tests

➥ By End-User: Hospitals, Diagnostic Centers, Others

Research Process:

Both primary and secondary data sources have been used in the Dengue Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Dengue Testing Market Research Industry:

➠ Who leads the Dengue Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Dengue Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Dengue Testing market growth?
➠ What are the dominant sales and distribution strategies in the Dengue Testing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=dengue-testing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.